Skip to content
Vatelizumab
Vatelizumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. It is known to target integrin alpha-2.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
4 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Relapsing-remitting multiple sclerosisD020529EFO_0003929—2———2
Ulcerative colitisD003093EFO_0000729K51—2———2
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameVATELIZUMAB
INNvatelizumab
Description
Vatelizumab (humanized mab)
Classification
Antibody
Drug classmonoclonal antibodies
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID1238217-55-4
RxCUI—
ChEMBL IDCHEMBL1743086
ChEBI ID—
PubChem CID—
DrugBankDB12346
UNII IDA4R7G50030 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
ITGA2
ITGA2
Organism
Homo sapiens
Gene name
ITGA2
Gene synonyms
CD49B
NCBI Gene ID
3673
Protein name
integrin alpha-2
Protein synonyms
alpha 2 integrin, alpha 2 subunit of VLA-2 receptor, CD49 antigen-like family member B, CD49b, Collagen receptor, glycoprotein Ia, GPIa, human platelet alloantigen 5, human platelet alloantigen system 5, integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor), platelet antigen Br, platelet glycoprotein GPIa, Platelet membrane glycoprotein Ia, very late activation protein 2 receptor, alpha-2 subunit, very late activation receptor alpha-2 subunit, very late activation receptor subunit alpha-2, VLA-2 subunit alpha
Uniprot ID
Q14595
Mouse ortholog
Itga2 (16398)
integrin alpha-2 (Q6P1C7)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 16 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details